MedApp Balance Sheet Health
Financial Health criteria checks 3/6
MedApp has a total shareholder equity of PLN26.1M and total debt of PLN1.9M, which brings its debt-to-equity ratio to 7.4%. Its total assets and total liabilities are PLN36.3M and PLN10.2M respectively.
Key information
7.4%
Debt to equity ratio
zł1.94m
Debt
| Interest coverage ratio | n/a |
| Cash | zł177.00k |
| Equity | zł26.09m |
| Total liabilities | zł10.24m |
| Total assets | zł36.33m |
Recent financial health updates
No updates
Recent updates
Why Investors Shouldn't Be Surprised By MedApp S.A.'s (WSE:MDA) 26% Share Price Surge
Mar 26
Is It Too Late To Consider Buying MedApp S.A. (WSE:MDA)?
Jan 29Can You Imagine How Jubilant MedApp's (WSE:MDA) Shareholders Feel About Its 292% Share Price Gain?
Mar 12MedApp S.A.'s (WSE:MDA) Stock Is Going Strong: Have Financials A Role To Play?
Jan 18Announcing: MedApp (WSE:MDA) Stock Soared An Exciting 363% In The Last Five Years
Nov 26
Financial Position Analysis
Short Term Liabilities: MDA's short term assets (PLN25.2M) exceed its short term liabilities (PLN9.2M).
Long Term Liabilities: MDA's short term assets (PLN25.2M) exceed its long term liabilities (PLN1.0M).
Debt to Equity History and Analysis
Debt Level: MDA's net debt to equity ratio (6.8%) is considered satisfactory.
Reducing Debt: MDA's debt to equity ratio has increased from 0% to 7.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MDA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: MDA has less than a year of cash runway if free cash flow continues to grow at historical rates of 22% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 03:56 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MedApp S.A. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adrian Kowollik | East Value Research GmbH |